Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Nov-Dec;48(6):654-658.
doi: 10.4103/0253-7613.194843.

Randomized, double-blind, comparative study of oral metronidazole and tinidazole in treatment of bacterial vaginosis

Indu M Raja  1 , Asha Basavareddy  2 , Deepali Mukherjee  1 , Bikash Ranjan Meher  3
Affiliations
Randomized Controlled Trial

Randomized, double-blind, comparative study of oral metronidazole and tinidazole in treatment of bacterial vaginosis

Indu M Raja et al. Indian J Pharmacol. 2016 Nov-Dec.

Abstract

Objective: To compare the efficacy and tolerability of oral metronidazole and tinidazole in patients with bacterial vaginosis (BV) using Amsel's criteria.

Patients and methods: This was a randomized double-blind study, conducted by the Departments of Pharmacology and Gynecology of a tertiary care teaching hospital. Patients diagnosed with BV received either tablet metronidazole 500 mg twice daily for 5 days or tablet tinidazole 500 mg once daily + one placebo for 5 days and instructed to come for follow-up at the 1st week and 4th week. They were categorized as cured, partially cured, and not cured based on Amsel's criteria at the end of the study and compared between two groups using Chi-square test.

Results: A total 120 women were enrolled in the study, of which 114 completed the study. The treatment arms were comparable. The cure rate with low-dose tinidazole was significantly more compared to metronidazole at 4th week (P = 0.0013), but not at 1st week (P = 0.242). The adverse drug reactions were less with tinidazole compared to metronidazole.

Conclusion: Tinidazole at lower dose offers a better efficacy than metronidazole in long-term cure rates and in preventing relapses with better side effect profile.

Keywords: Bacterial vaginosis; cure rate; metronidazole; tinidazole; tolerability.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Consort diagram
Figure 2
Figure 2
Adverse drug reaction profifile in both groups. *Signifificant difference between metronidazole and tinidazole using Chi-square test, P = 0.03
See this image and copyright information in PMC

References

    1. Marrazzo JM, Martin DH, Fredricks DN. Bacterial Vaginosis: Identifying Research Gaps Proceedings of a Workshop Sponsored by DHHS/NIH/NIAID. 2008 Nov 19-20; - PMC - PubMed
    1. Krasnopolsky VN, Prilepskaya VN, Polatti F, Zarochentseva NV, Bayramova GR, Caserini M, et al. Efficacy of Vitamin C vaginal tablets as prophylaxis for recurrent bacterial vaginosis: A randomised, double-blind, placebo-controlled clinical trial. J Clin Med Res. 2013;5:309–15. - PMC - PubMed
    1. Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis. 2007;34:864–9. - PubMed
    1. Brotman RM, Klebanoff MA, Nansel TR, Yu KF, Andrews WW, Zhang J, et al. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis. 2010;202:1907–15. - PMC - PubMed
    1. Allsworth JE, Lewis VA, Peipert JF. Viral sexually transmitted infections and bacterial vaginosis: 2001-2004 national health and nutrition examination survey data. Sex Transm Dis. 2008;35:791–6. - PubMed

Publication types